Open AccessGUILLAIN-BARRÉ SYNDROME ASSOCIATED WITH SARS-COV-2 INFECTION, CASE REPORT
Author(s) -
Gabriela Maria de Oliveira Spindola,
Álvaro Moreira Rivelli,
Raphaela Aparecida Gonçalves dos Santos,
Sheila Fernandes Moreira,
Allan Salvador Pereira
Publication year - 2021
Publication title -
health and society
Language(s) - English
Resource type - Journals
ISSN - 2763-5724
DOI - 10.51249/hes01.02.2021.297
Subject(s) - guillain barre syndrome , medicine , acute disseminated encephalomyelitis , polyradiculoneuropathy , multiple sclerosis , encephalitis , pandemic , covid-19 , disease , peripheral nervous system , stroke (engine) , immunology , intensive care medicine , pediatrics , central nervous system , pathology , virus , infectious disease (medical specialty) , mechanical engineering , engineering
Considered a respiratory infection, COVID-19 can lead to neurological pathologies, including encephalitis, stroke, acute disseminated encephalomyelitis and peripheral neuropathies, such as Guillain-Barré syndrome. Guillain-Barré syndrome, also known as acute polyradiculoneuropathy, is an autoimmune disease of the nervous system. Its main manifestation is the acute inflammation of the nerves and nerve roots, attacking the myelin sheath. Bearing in mind the relationship between neurological disorders and COVID-19, the doctor can adopt the best approach for each case, knowing that the neurological manifestations of COVID-19 are varied and that the data on them continue to evolve as the pandemic progresses.